Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 12
Submit an article Journal homepage
91
Views
12
CrossRef citations to date
0
Altmetric
Review

Roles of microRNAs and their targets in cancer

Giovanni Stefani Yale University, Department of Molecular, Cellular and Developmental Biology, 266 Whitney Avenue, New Haven, CT 06520, USA +1 203 432 4941; +1 203 432 6161; [email protected]
Pages 1833-1840 | Published online: 22 Nov 2007

Bibliography

  • ESQUELA-KERSCHER A, SLACK FJ: Oncomirs – microRNAs with a role in cancer. Nat. Rev. Cancer (2006) 6:259-269.
  • CALIN GA, CROCE CM: MicroRNA signatures in human cancers. Nat. Rev. Cancer (2006) 6:857-866.
  • KENT OA, MENDELL JT: A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene (2006) 25:6188-6196.
  • BARTEL DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 116:281-297.
  • MOLNAR A, SCHWACH F, STUDHOLME DJ, THUENEMANN EC, BAULCOMBE DC: miRNAs control gene expression in the single-cell alga Chlamydomonas reinhardtii. Nature (2007) 447:1126-1129.
  • LEE Y, AHN C, HAN J et al.: The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 425:415-419.
  • RUBY JG, JAN CH, BARTEL DP: Intronic microRNA precursors that bypass Drosha processing. Nature (2007) 448:83-86.
  • OKAMURA K, HAGEN JW, DUAN H, TYLER DM, LAI EC: The Mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell (2007) 130(1):89-100.
  • CHAN SP, SLACK FJ: microRNA-mediated silencing inside P-bodies. RNA Biol. (2006) 3:97-100.
  • STANDART N, JACKSON RJ: MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation. Genes Dev. (2007) 21:1975-1982.
  • LEE RC, FEINBAUM RL, AMBROS V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 75:843-854.
  • WIGHTMAN B, HA I, RUVKUN G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell (1993) 75:855-862.
  • REINHART BJ, SLACK FJ, BASSON M et al.: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature (2000) 403:901-906.
  • PASQUINELLI AE, REINHART BJ, SLACK F et al.: Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 408:86-89.
  • LAGOS-QUINTANA M, RAUHUT R, LENDECKEL W, TUSCHL T: Identification of novel genes coding for small expressed RNAs. Science (2001) 294:853-858.
  • LAU NC, LIM LP, WEINSTEIN EG, BARTEL DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science (2001) 294:858-862.
  • LEE RC, AMBROS V: An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 294:862-864.
  • JOHNSON SM, GROSSHANS H, SHINGARA J et al.: RAS is regulated by the let-7 microRNA family. Cell (2005) 120:635-647.
  • GROSSHANS H, JOHNSON T, REINERT KL, GERSTEIN M, SLACK FJ: The temporal patterning microRNA let-7 regulates several transcription factors at the larval to adult transition in C. elegans. Dev. Cell (2005) 8:321-330.
  • TAKAMIZAWA J, KONISHI H, YANAGISAWA K et al.: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. (2004) 64:3753-3756.
  • YANAIHARA N, CAPLEN N, BOWMAN E et al.: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 9:189-198.
  • SGARRA R, RUSTIGHI A, TESSARI MA et al.: Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett. (2004) 574:1-8.
  • LEE YS, DUTTA A: The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. (2007) 21:1025-1030.
  • MAYR C, HEMANN MT, BARTEL DP: Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (2007) 315:1576-1579.
  • JOHNSON CD, ESQUELA-KERSCHER A, STEFANI G et al.: The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. (2007) 67:7713-7722.
  • BULLRICH F, FUJII H, CALIN G et al.: Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res. (2001) 61:6640-6648.
  • CALIN GA, DUMITRU CD, SHIMIZU M et al.: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA (2002) 99:15524-15529.
  • CIMMINO A, CALIN GA, FABBRI M et al.: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA (2005) 102:13944-13949.
  • TSUJIMOTO Y, GORHAM J, COSSMAN J, JAFFE E, CROCE CM: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science (1985) 229:1390-1393.
  • CLURMAN BE, HAYWARD WS: Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol. Cell Biol. (1989) 9:2657-2664.
  • TAM W, BEN-YEHUDA D, HAYWARD WS: Bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell Biol. (1997) 17:1490-1502.
  • METZLER M, WILDA M, BUSCH K, VIEHMANN S, BORKHARDT A: High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer (2004) 39:167-169.
  • IORIO MV, FERRACIN M, LIU CG et al.: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. (2005) 65:7065-7070.
  • EIS PS, TAM W, SUN L et al.: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA (2005) 102:3627-3632.
  • VAN DEN BERG A, KROESEN BJ, KOOISTRA K et al.: High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer (2003) 37:20-28.
  • KLUIVER J, HARALAMBIEVA E, DE JONG D et al.: Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer (2006) 45:147-153.
  • KLUIVER J, POPPEMA S, DE JONG D et al.: BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. (2005) 207:243-249.
  • THAI TH, CALADO DP, CASOLA S et al.: Regulation of the germinal center response by microRNA-155. Science (2007) 316:604-608.
  • RODRIGUEZ A, VIGORITO E, CLARE S et al.: Requirement of bic/microRNA-155 for normal immune function. Science (2007) 316:608-611.
  • CALIN GA, SEVIGNANI C, DUMITRU CD et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA (2004) 101:2999-3004.
  • HOLLSTEIN M, SIDRANSKY D, VOGELSTEIN B, HARRIS CC: p53 mutations in human cancers. Science (1991) 253:49-53.
  • LEVINE AJ, HU W, FENG Z: The P53 pathway: what questions remain to be explored? Cell Death Differ. (2006) 13:1027-1036.
  • CHANG TC, WENTZEL EA, KENT OA et al.: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell (2007) 26:745-752.
  • RAVER-SHAPIRA N, MARCIANO E, MEIRI E et al.: Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell (2007) 26:731-743.
  • HE L, HE X, LIM LP et al.: A microRNA component of the p53 tumour suppressor network. Nature (2007) 447(7148):1130-1134.
  • VOORHOEVE PM, LE SAGE C, SCHRIER M et al.: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell (2006) 124:1169-1181.
  • CHEN CY, SHYU AB: AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. (1995) 20:465-470.
  • JING Q, HUANG S, GUTH S et al.: Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell (2005) 120:623-634.
  • O'DONNELL KA, WENTZEL EA, ZELLER KI, DANG CV, MENDELL JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 435:839-843.
  • OTA A, TAGAWA H, KARNAN S et al.: Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. (2004) 64:3087-3095.
  • HE L, THOMSON JM, HEMANN MT et al.: A microRNA polycistron as a potential human oncogene. Nature (2005) 435:828-833.
  • HAYASHITA Y, OSADA H, TATEMATSU Y et al.: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. (2005) 65:9628-9632.
  • VOLINIA S, CALIN GA, LIU CG et al.: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA (2006) 103:2257-2261.
  • DEGREGORI J, JOHNSON DG: Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. (2006) 6:739-748.
  • LEWIS BP, SHIH IH, JONES-RHOADES MW, BARTEL DP, BURGE CB: Prediction of mammalian microRNA targets. Cell (2003) 115:787-798.
  • KRICHEVSKY AM, KING KS, DONAHUE CP, KHRAPKO K, KOSIK KS: A microRNA array reveals extensive regulation of microRNAs during brain development. RNA (2003) 9:1274-1281.
  • LIU CG, CALIN GA, MELOON B et al.: An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl. Acad. Sci. USA (2004) 101:9740-9744.
  • MISKA EA, ALVAREZ-SAAVEDRA E, TOWNSEND M et al.: Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. (2004) 5:R68.
  • SEMPERE LF, FREEMANTLE S, PITHA-ROWE I, MOSS E, DMITROVSKY E, AMBROS V: Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. (2004) 5:R13.
  • SMIRNOVA L, GRAFE A, SEILER A, SCHUMACHER S, NITSCH R, WULCZYN FG: Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. (2005) 21:1469-1477.
  • SUN Y, KOO S, WHITE N et al.: Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. (2004) 32:E188.
  • MONTICELLI S, ANSEL KM, XIAO C et al.: MicroRNA profiling of the murine hematopoietic system. Genome Biol. (2005) 6:R71.
  • BABAK T, ZHANG W, MORRIS Q, BLENCOWE BJ, HUGHES TR: Probing microRNAs with microarrays: tissue specificity and functional inference. RNA (2004) 10:1813-1819.
  • LU J, GETZ G, MISKA EA et al.: MicroRNA expression profiles classify human cancers. Nature (2005) 435:834-838.
  • LI J, SMYTH P, FLAVIN R et al.: Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol. (2007) 7:36.
  • XI Y, NAKAJIMA G, GAVIN E et al.: Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA (2007) 13(10):1668-1674.
  • THOMSON JM, NEWMAN M, PARKER JS, MORIN-KENSICKI EM, WRIGHT T, HAMMOND SM: Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. (2006) 20:2202-2207.
  • KUMAR MS, LU J, MERCER KL, GOLUB TR, JACKS T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. (2007) 39:673-677.
  • SLACK FJ, WEIDHAAS JB: MicroRNAs as a potential magic bullet in cancer. Future Oncol. (2006) 2:73-82.
  • RANA TM: Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. (2007) 8:23-36.
  • DE FOUGEROLLES A, VORNLOCHER HP, MARAGANORE J, LIEBERMAN J: Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov. (2007) 6:443-453.
  • JACKSON AL, BARTZ SR, SCHELTER J et al.: Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. (2003) 21:635-637.
  • JACKSON AL, BURCHARD J, SCHELTER J et al.: Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. RNA (2006) 12:1179-1187.
  • JACKSON AL, LINSLEY PS: Noise amidst the silence: off-target effects of siRNAs? Trends Genet. (2004) 20:521-524.
  • WEILER J, HUNZIKER J, HALL J: Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther. (2006) 13:496-502.
  • KRUTZFELDT J, KUWAJIMA S, BRAICH R et al.: Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. (2007) 35:2885-2892.
  • KRUTZFELDT J, RAJEWSKY N, BRAICH R et al.: Silencing of microRNAs invivo with ‘antagomirs’. Nature (2005) 438:685-689.
  • WAEHLER R, RUSSELL SJ, CURIEL DT: Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. (2007) 8(8):573-587.
  • MACK GS: MicroRNA gets down to business. Nat. Biotechnol. (2007) 25:631-638.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.